A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal

Cancer Cell

Volumn 24, Issue 1, 2013, Pages 59-74

  Zheng, Yanyan ^a   de la Cruz, Cecile C ^b   Sayles, Leanne C ^a   Alleyne Chin, Chris ^a,d   Vaka, Dedeepya ^a   Knaak, Tim D ^c   Bigos, Marty ^c   Xu, Yue ^a   Hoang, Chuong D ^a   Shrager, Joseph B ^a   Fehling, HansJoerg ^e   French, Dorothy ^b   Forrest, William ^b   Jiang, Zhaoshi ^b   Carano, Richard A D ^b   Barck, Kai H ^b   Jackson, Erica L ^b   Sweet Cordero, E Alejandro ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c STANFORD UNIVERSITY   (United States)

^d SAN FRANCISCO STATE UNIVERSITY   (United States)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; CD24 ANTIGEN; CISPLATIN; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CELL HETEROGENEITY; CELL POPULATION; CELL RENEWAL; CLONOGENESIS; CONTROLLED STUDY; HUMAN; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THERAPY RESISTANCE; TUMOR CELL; TUMOR GROWTH; TUMOR PROPAGATING CELL; TUMOR SPHEROID;

EID: 84880023918     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.05.021     Document Type: Article

References (53)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
2. Allen T.D., Rodriguez E.M., Jones K.D., Bishop J.M. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res. 2011, 71:6010-6018.
3. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
4. Beverly L.J., Felsher D.W., Capobianco A.J. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer Res. 2005, 65:7159-7168.
5. Caunt M., Mak J., Liang W.C., Stawicki S., Pan Q., Tong R.K., Kowalski J., Ho C., Reslan H.B., Ross J., et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 2008, 13:331-342.
6. Chapman H.A., Li X., Alexander J.P., Brumwell A., Lorizio W., Tan K., Sonnenberg A., Wei Y., Vu T.H. Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice. J.Clin. Invest. 2011, 121:2855-2862.
7. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
8. Cui F., Wang J., Chen D., Chen Y.J. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer. Oncol. Rep. 2011, 25:701-708.
9. Curtis S.J., Sinkevicius K.W., Li D., Lau A.N., Roach R.R., Zamponi R., Woolfenden A.E., Kirsch D.G., Wong K.K., Kim C.F. Primary tumor genotype is an important determinant in identification of lung cancer propagating cells. Cell Stem Cell 2010, 7:127-133.
10. Dang T.P., Gazdar A.F., Virmani A.K., Sepetavec T., Hande K.R., Minna J.D., Roberts J.R., Carbone D.P. Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J.Natl. Cancer Inst. 2000, 92:1355-1357.
11. Dang T.P., Eichenberger S., Gonzalez A., Olson S., Carbone D.P. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice. Oncogene 2003, 22:1988-1997.
12. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15:504-514.
13. Fan X., Khaki L., Zhu T.S., Soules M.E., Talsma C.E., Gul N., Koh C., Zhang J., Li Y.M., Maciaczyk J., et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010, 28:5-16.
14. Guo W., Lasky J.L., Chang C.J., Mosessian S., Lewis X., Xiao Y., Yeh J.E., Chen J.Y., Iruela-Arispe M.L., Varella-Garcia M., Wu H. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008, 453:529-533.
15. Guseh J.S., Bores S.A., Stanger B.Z., Zhou Q., Anderson W.J., Melton D.A., Rajagopal J. Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. Development 2009, 136:1751-1759.
16. Harrison H., Farnie G., Howell S.J., Rock R.E., Stylianou S., Brennan K.R., Bundred N.J., Clarke R.B. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 2010, 70:709-718.
17. Haruki N., Kawaguchi K.S., Eichenberger S., Massion P.P., Olson S., Gonzalez A., Carbone D.P., Dang T.P. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res. 2005, 65:3555-3561.
18. Hegde G.V., de la Cruz C.C., Chiu C., Alag N., Schaefer G., Crocker L., Ross S., Goldenberg D., Merchant M., Tien J., et al. Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancer. Sci. Transl. Med. 2013, 5. 171ra118.
19. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
20. Herzenberg L.A., Tung J., Moore W.A., Herzenberg L.A., Parks D.R. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 2006, 7:681-685.
21. Hoey T., Yen W.C., Axelrod F., Basi J., Donigian L., Dylla S., Fitch-Bruhns M., Lazetic S., Park I.K., Sato A., et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 2009, 5:168-177.
22. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., Tuveson D.A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001, 15:3243-3248.
23. Jackson E.L., Olive K.P., Tuveson D.A., Bronson R., Crowley D., Brown M., Jacks T. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res. 2005, 65:10280-10288.
24. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
25. Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 2001, 29:418-425.
26. Kannan S., Sutphin R.M., Hall M.G., Golfman L.S., Fang W., Nolo R.M., Akers L.J., Hammitt R.A., McMurray J.S., Kornblau S.M., et al. Notch activation inhibits AML growth and survival: a potential therapeutic approach. J.Exp. Med. 2013, 210:321-337.
27. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
28. Konishi J., Yi F., Chen X., Vo H., Carbone D.P., Dang T.P. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. Oncogene 2010, 29:589-596.
29. Lee T.K.W., Castilho A., Cheung V.C.H., Tang K.H., Ma S., Ng I.O.L. CD24+ liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 2011, 9:50-63.
30. Leung E.L., Fiscus R.R., Tung J.W., Tin V.P., Cheng L.C., Sihoe A.D., Fink L.M., Ma Y., Wong M.P. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS ONE 2010, 5:e14062.
31. Lobry C., Ntziachristos P., Ndiaye-Lobry D., Oh P., Cimmino L., Zhu N., Araldi E., Hu W., Freund J., Abdel-Wahab O., et al. Notch pathway activation targets AML-initiating cell homeostasis and differentiation. J.Exp. Med. 2013, 210:301-319.
32. Luche H., Weber O., Nageswara Rao T., Blum C., Fehling H.J. Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies. Eur. J. Immunol. 2007, 37:43-53.
33. Maraver A., Fernandez-Marcos P.J., Herranz D., Cañamero M., Muñoz-Martin M., Gómez-López G., Mulero F., Megías D., Sanchez-Carbayo M., Shen J., et al. Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell 2012, 22:222-234.
34. Marjanovic N.D., Weinberg R.A., Chaffer C.L. Cell plasticity and heterogeneity in cancer. Clin. Chem. 2013, 59:168-179.
35. McQualter J.L., Brouard N., Williams B., Baird B.N., Sims-Lucas S., Yuen K., Nilsson S.K., Simmons P.J., Bertoncello I. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 2009, 27:623-633.
36. McQualter J.L., Yuen K., Williams B., Bertoncello I. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc. Natl. Acad. Sci. USA 2010, 107:1414-1419.
37. Meng X., Li M., Wang X., Wang Y., Ma D. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci. 2009, 100:1040-1046.
38. Mimae T., Okada M., Hagiyama M., Miyata Y., Tsutani Y., Inoue T., Murakami Y., Ito A. Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin. Cancer Res. 2012, 18:945-955.
39. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
40. Phillips T.M., McBride W.H., Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J.Natl. Cancer Inst. 2006, 98:1777-1785.
41. Ranganathan P., Weaver K.L., Capobianco A.J. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat. Rev. Cancer 2011, 11:338-351.
42. Shafee N., Smith C.R., Wei S., Kim Y., Mills G.B., Hortobagyi G.N., Stanbridge E.J., Lee E.Y. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Res. 2008, 68:3243-3250.
43. Shedden K., Taylor J.M., Enkemann S.A., Tsao M.S., Yeatman T.J., Gerald W.L., Eschrich S., Jurisica I., Giordano T.J., Misek D.E., et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med. 2008, 14:822-827. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma.
44. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
45. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 2001, 1:4.
46. Teisanu R.M., Lagasse E., Whitesides J.F., Stripp B.R. Prospective isolation of bronchiolar stem cells based upon immunophenotypic and autofluorescence characteristics. Stem Cells 2009, 27:612-622.
47. Tirino V., Camerlingo R., Franco R., Malanga D., La Rocca A., Viglietto G., Rocco G., Pirozzi G. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur. J. Cardiothorac. Surg. 2009, 36:446-453.
48. Tsao P.N., Chen F., Izvolsky K.I., Walker J., Kukuruzinska M.A., Lu J., Cardoso W.V. Gamma-secretase activation of notch signaling regulates the balance of proximal and distal fates in progenitor cells of the developing lung. J.Biol. Chem. 2008, 283:29532-29544.
49. van Es J.H., van Gijn M.E., Riccio O., van den Born M., Vooijs M., Begthel H., Cozijnsen M., Robine S., Winton D.J., Radtke F., Clevers H. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963.
50. Vermeulen L., Todaro M., de Sousa Mello F., Sprick M.R., Kemper K., Perez Alea M., Richel D.J., Stassi G., Medema J.P. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 2008, 105:13427-13432.
51. Vicent S., Sayles L.C., Vaka D., Khatri P., Gevaert O., Chen R., Zheng Y., Gillespie A.K., Clarke N., Xu Y., et al. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer invivo. Cancer Res. 2012, 72:5744-5756.
52. Westhoff B., Colaluca I.N., D'Ario G., Donzelli M., Tosoni D., Volorio S., Pelosi G., Spaggiari L., Mazzarol G., Viale G., et al. Alterations of the Notch pathway in lung cancer. Proc. Natl. Acad. Sci. USA 2009, 106:22293-22298.
53. Zhang W.C., Shyh-Chang N., Yang H., Rai A., Umashankar S., Ma S., Soh B.S., Sun L.L., Tai B.C., Nga M.E., et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 2012, 148:259-272.